openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Annovis Bio, Inc. (NYSE: ANVS) over possible Wrongdoing

10-26-2021 07:01 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Annovis Bio, Inc. (NYSE: ANVS) shares.

An investigation on behalf of current long term investors in Annovis Bio, Inc. (NYSE: ANVS) shares.

An investigation was announced over possible breaches of fiduciary duties by certain directors and officers of Annovis Bio, Inc..

Investors who are current long term investors in Annovis Bio, Inc. (NYSE: ANVS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NYSE: ANVS stocks follows a lawsuit filed against Annovis Bio, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE: ANVS stocks, concerns whether certain Annovis Bio directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges that the Defendants failed to disclose to investors: (1) that Annovis’s ANVS401 did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result, Defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.

Those who purchased shares of Annovis Bio, Inc. (NYSE: ANVS) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Annovis Bio, Inc. (NYSE: ANVS) over possible Wrongdoing here

News-ID: 2442921 • Views: 498

More Releases from Shareholders Foundation

Investigation announced for Investors in Kiora Pharmaceuticals, Inc. (NASDAQ: KP …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Kiora Pharmaceuticals, Inc f.k.a EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG). Investors who purchased shares of Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Kiora Pharmaceuticals directors breached their fiduciary duties and caused damage to
Investigation announced for Long-Term Investors in Avalo Therapeutics, Inc. (NAS …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Avalo Therapeutics, Inc f.k.a. Cerecor Inc. Investors who purchased shares of Avalo Therapeutics, Inc. (NASDAQ: AVTX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Avalo Therapeutics, Inc. officers and directors breached their fiduciary duties and caused damage to
Investigation announced for Investors in shares of Live Nation Entertainment, In …
An investigation was announced over potential securities laws violations in connection with certain statements. Investors who purchased shares of Live Nation Entertainment, Inc. (NYSE: LYV), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether certain statements by Live Nation Entertainment, Inc. (NYSE: LYV regarding its business, its prospects and its operations were materially false and
Notice for Investors in NYSE: AAP shares: Update in Lawsuit against Advance Auto …
A lawsuit is currently pending for certain investors in shares of Advance Auto Parts, Inc. (NYSE: AAP). Investors who purchased shares of Advance Auto Parts, Inc. (NYSE: AAP) and currently hold any of those Advance Auto Parts, Inc. (NYSE: AAP shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Advance Auto Parts, Inc. (NYSE:

All 5 Releases


More Releases for Annovis

Global Down syndrome market Is Projected To Witness Vigorous Expansion By 2026 | …
Global Down Syndrome Market research report has been prepared with a nice combination of industry insight, smart solutions, practical solutions and newest technology to give better user experience. Under market segmentation chapter, research and analysis is done based on several market and industry segments such as application, vertical, deployment model, end user, and geography. To perform this market research study, competent and advanced tools and techniques have been utilized that
Global Down syndrome market Surprising Growth due to Covid 19 include Major Play …
Key players in the market, major collaborations, merger and acquisitions along with trending innovation and business policies are reviewed in this persuasive Global Down Syndrome Market report. Besides, this market research report makes clients aware about the various strategies that are used by key players of the market. Competitor analysis is a vital aspect of this market research report which focuses on strong and weak points of the competitors and
Global Down syndrome market Overview With Detailed Analysis, Competitive Landsca …
DBMR has added a new report titled Global Down syndrome market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. This Global Down syndrome market report is quite useful to find out the general market conditions and tendencies. It also estimates the probable market for a new product to be launched in the market. This also Report